MedPath
NMPA Approval

Rilpivirine Injection

国药准字HJ20230117

October 18, 2023

Drug Information

利匹韦林注射液

注射剂

2ml∶0.6g

化学药品

October 18, 2023

October 17, 2028

Company Information

Applicant Company

Turnhoutseweg 30, B-2340 Beerse, Belgium

Manufacturing Company

Cilag AG

Hochstrasse 201, 8200 Schaffhausen, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利匹韦林注射液 - NMPA 批准文号 | MedPath